What is Avanos Medical's other commercial liabilities?

Avanos Medical (AVNS) reported other commercial liabilities of $57.6M in Q1 2026.

How has Avanos Medical's other commercial liabilities changed year-over-year?

Avanos Medical's other commercial liabilities decreased by 19.3% year-over-year, from $71.4M to $57.6M.

What is the long-term trend for Avanos Medical's other commercial liabilities?

Over 5 years (2020 to 2025), Avanos Medical's other commercial liabilities has grown at a 1.9% compound annual growth rate (CAGR), from $83.2M to $91.3M.

Avanos Medical AVNS Other Commercial Liabilities

Other Commercial Liabilities at other companies

Boston ScientificBSX

——

Pacira BioSciences, Inc.PCRX

——

Collegium Pharmaceutical, Inc.COLL

——

IAR

Integra LifeSciencesIART

——

AMN HealthcareAMN

——

Baxter InternationalBAX

——

Other financials

Income statement

See full

Revenue$182.2M+8.8%

Gross profit$94.2M+4.9%

Operating income$8.9M-13.6%

Net income$5.1M-22.7%

EPS (diluted)$0.11-21.4%

Balance sheet

See full

Cash & equivalents$65.6M-32.4%

Total debt$138.4M-1.8%

Total equity$782.1M-6.8%

Total assets$1.1B-5.2%

Cash flow

See full

Operating cash flow-$12.3M-148%

CapEx$4.3M-35.8%

Free cash flow-$16.6M-187%

Valuation

See full

Market cap$1.17B+108%

Enterprise value$1.24B+105%

P/S1.6×+0.8×

Profitability

See full

Gross margin50%-4.6pp

Operating margin-9.1%-4.2pp

Net margin-10.4%-4.7pp

FCF margin1.6%-14.9pp

Returns & leverage

See full

Return on equity-9.2%-3.9pp

Debt / equity0.2×0.0×

Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avanos Medical's other commercial liabilities?: Avanos Medical (AVNS) reported other commercial liabilities of $57.6M in Q1 2026.
How has Avanos Medical's other commercial liabilities changed year-over-year?: Avanos Medical's other commercial liabilities decreased by 19.3% year-over-year, from $71.4M to $57.6M.
What is the long-term trend for Avanos Medical's other commercial liabilities?: Over 5 years (2020 to 2025), Avanos Medical's other commercial liabilities has grown at a 1.9% compound annual growth rate (CAGR), from $83.2M to $91.3M.